EUVIMEDEUVIMED entdecken
Crossref

Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation

Walter Masson, Gabriel Waisman, Pablo Corral, Augusto Lavalle-Cobo, Melina Huerin, Leandro Barbagelata, Daniel Siniawski

High Blood Pressure & Cardiovascular Prevention · 2024

DOI: 10.1007/s40292-024-00649-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift High Blood Pressure & Cardiovascular Prevention, 2024. Verfasst von Walter Masson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Italiano de Buenos Aires, Perón 4190, C1199ABB, Ciudad Autónoma de Buenos Aires, Argentina. walter.masson@hospital…. Hauptthemen laut MEDLINE: Biomarkers, Blood Pressure, Cardiovascular Diseases, Cholesterol, LDL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: A new cardiovascular risk (CVR) calculator that incorporates Lipoprotein(a) [Lp(a)] levels has recently been designed. AIMS: To estimate CVR using the new score and to identify the reduction in low-density lipoprotein cholesterol (LDL-C) or systolic blood pressure (SBP) necessary to balance the risk attributable to Lp(a). METHODS: CVR throughout life and at 10 years was estimated with the new score in patients in primary prevention, both considering and not considering the value of Lp(a). When the estimated risk considering Lp(a) levels exceeded the baseline risk, the reduction in LDL-C levels or SBP necessary to balance the risk attributable to Lp(a) was calculated. RESULTS: In total, 671 patients (mean age 54.2 years, 47.2% women) were included. Globally, 22.7% of the population had high Lp(a) values (> 50 mg/dL or > 125 nmol/L). When calculating CVR throughout life and considering the Lp(a) value, the global risk increased in 66.7% of cases (median 19.3%). Similar results were observed when we assessed the 10-year risk. The risk associated with Lp(a) could be completely compensated by decreasing LDL-C (average 21 mg/dL) or SBP (average 6.3 mmHg) in 79.2% and 74.7% of cases, respectively. CONCLUSION: When calculating the CVR with the new score, two-thirds and one-third of the population were bidirectionally recategorized as 'up' or 'down,' respectively. The decrease in LDL-C or SBP mitigated the increased risk caused by Lp(a) levels across a substantial proportion of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersBlood PressureCardiovascular DiseasesCholesterol, LDLHeart Disease Risk FactorsLipoprotein(a)Predictive Value of TestsFemaleHumansMaleMiddle AgedDecision Support TechniquesDyslipidemiasPrimary PreventionPrognosisRisk AssessmentTime Factors

Stichwörter der Autor:innen

Cardiovascular riskLipoprotein(a)Low-density lipoprotein cholesterolSystolic blood pressure

Substanzen

BiomarkersCholesterol, LDLLipoprotein(a)LPA protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Hospital Italiano de Buenos Aires, Perón 4190, C1199ABB, Ciudad Autónoma de Buenos Aires, Argentina. walter.masson@hospitalitaliano.org.ar.
  • Argentine Group for the Study of Lp(a) [GAELp(a)], Buenos Aires, Argentina. walter.masson@hospitalitaliano.org.ar.
  • Lezica Cardiovascular Institute, San Isidro, Argentina.
  • Argentine Group for the Study of Lp(a) [GAELp(a)], Buenos Aires, Argentina.
  • Faculty of Medicine, FASTA University, Mar del Plata, Argentina.
  • Otamendi Sanatorium, Buenos Aires, Argentina.

Zitieren

APA

Masson, W., Waisman, G., Corral, P., Lavalle-Cobo, A., Huerin, M., Barbagelata, L., & Siniawski, D. (2024). Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation. High Blood Pressure & Cardiovascular Prevention. https://doi.org/10.1007/s40292-024-00649-x

Vancouver

Masson W, Waisman G, Corral P, Lavalle-Cobo A, Huerin M, Barbagelata L, et al. Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation. High Blood Pressure & Cardiovascular Prevention. 2024. doi:10.1007/s40292-024-00649-x

BibTeX
@article{Masson2024,
  author = {Masson, Walter and Waisman, Gabriel and Corral, Pablo and Lavalle-Cobo, Augusto and Huerin, Melina and Barbagelata, Leandro and Siniawski, Daniel},
  title = {Impact of Lipoprotein(a) Levels on Cardiovascular Risk Estimation},
  journal = {High Blood Pressure & Cardiovascular Prevention},
  year = {2024},
  doi = {10.1007/s40292-024-00649-x}
}
Kostenlos starten →